CTRI/2024/02/063312
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of NARKARANTHAI LEGHIYAM alongwith the external application of KARBOGI PASAI in the management of PADARTHAMARAI (DERMATOPHYTOSIS) in children - NI
Dr. M. Venkalaisuratha0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr. M. Venkalaisuratha
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Both male and female children
- •Tinea corporis
- •Tinea capitis
- •Tinea cruris
- •Tinea unguium
Exclusion Criteria
- •Secondary skin infection
- •Bleeding skin infections
- •Lichen plannus
- •Tinea barbae
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of SINGATHI CHOORANAM along with external application of PEENASA THYLAMin the management of BACTERIAL SINUSITISin paediatric age group.CTRI/2022/10/046870Dr M Selvarathi
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of VAANI KIRUTHAM along with external application of VILVAPAZHA THYLUM with the procedure of SIRASU THAARAI in the management of ATTENTION DEFICIT HYPERACTIVITY DISORDER in paediatric age groupCTRI/2022/11/047018DR SUBBULAKSHMI S
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of MANTHARA KAASA LEGIYAM in the management of PRIMARY COMPLEX in childreHealth Condition 1: A150- Tuberculosis of lungCTRI/2022/11/046963Dr A Rathi
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of SEENTHIL KIRUTHAM (oral administration) and KUPPAIMENI THAILAM (external application) in the management of SCABIES in childreCTRI/2022/10/046867Dr K Gowsalya
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of ATHIMADHURA CHOORANAM (oral administration) in the management of JAUNDICEHealth Condition 1: R17- Unspecified jaundiceCTRI/2022/10/046821Dr R S BRATHEESHA